Sanofi India Receives Assessment Order from Income Tax Department

Sanofi India Receives Assessment Order from Income Tax Department​

Sanofi India Limited announced receipt of a final assessment order from the Assessment Unit of the Income Tax Department on March 27, 2026. The order pertains to the financial year 2022-23 (Assessment Year 2023-24) and determines a tax liability of INR 12,36,99,710, inclusive of interest.

The assessment order includes adjustments related to transfer pricing issues and disallowances for payments made to healthcare professionals.

Sanofi India intends to appeal the adjustments and disallowances to higher tax authorities. The company anticipates the matter will impact its financial activities.

Source:​

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.